Doxorubicin Hydrochloride
- Product NDC
- 43598-682
- 11-digit product format
- 435980682
- Labeler code
- 43598
- Product ID
- 43598-682_ffeb761a-aab9-be2c-c0d6-efd6421dfeb3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxorubicin Hydrochloride
- Dosage form
- INJECTABLE, LIPOSOMAL
- Route
- INTRAVENOUS
- Labeler
- Dr. Reddy's Laboratories Inc
- Application
- ANDA208657
- Marketing category
- ANDA
- Marketing start
- 2018-03-13
- Marketing end
- 0000-00-00
- Substance
- DOXORUBICIN HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [CS],Topoisomerase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43598-682 | DOXORUBICIN HYDROCHLORIDE INJECTABLE, LIPOSOMAL [DR. REDDY'S LABORATORIES INC] | 5 | Legacy NDC | 20230411_8216352e-dbf6-b1b0-3ae6-614ed44ef55e.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43598-682-35 | 43598068235 | 1 VIAL, SINGLE-DOSE in 1 PACKAGE (43598-682-35) > 10 mL in 1 VIAL, SINGLE-DOSE | 2018-03-13 | 0000-00-00 | No | No | Current |